469 Treffer:
11.
A Randomized, Double-blind, Multiregional Phase 3 Study of Ivonescimab Combined with Chemotherapy Versus Pembrolizumab Combined with Chemotherapy for the First-line Treatment of Metastatic Non-small Cell Lung Cancer (HARMONi-3)
NCT Heidelberg » Für Ärzte » Studien » Thorakale Tumoren » Bronchialkarzinom
Datum: 2025-10-24
12.
A Platform Study of RAS(ON) Inhibitor Combinations in Patients with RAS-Mutated Non-Small Cell Lung Cancer (NSCLC)
NCT Heidelberg » Für Ärzte » Studien » Thorakale Tumoren » Bronchialkarzinom
Datum: 2025-10-24
13.
Beamion LUNG 2: A Phase III, Open-label, Randomized, Active-controlled, Multi-centre Trial Evaluating Orally Administered Zongertinib (BI 1810631) Compared With Standard of Care as First-line Treatment in Patients With Unresectable, Locally Advanced or Me
NCT Heidelberg » Für Ärzte » Studien » Thorakale Tumoren » Bronchialkarzinom
Datum: 2025-10-24
14.
DAREON™-9: A Phase Ib Open-label Dose Escalation and Dose Confirmation Safety Study of Intravenous BI 764532 in Combination With Topotecan for the Treatment of Patients With Small Cell Lung Cancer
NCT Heidelberg » Für Ärzte » Studien » Thorakale Tumoren » Bronchialkarzinom
Datum: 2025-10-24
15.
PHASE III STUDY COMPARING TRABECTEDIN (T) VERSUS T PLUS tTF-NGR TO ENTRAP T INSIDE THE TUMOR IN PATIENTS WITH METASTATIC AND/OR REFRACTORY SOFT TISSUE SARCOMA (STS)
NCT Heidelberg » Für Ärzte » Studien » Sarkome » Weichteilsarkome
Datum: 2025-10-24
16.
Randomized, Controlled, Open-label, Phase IIb/III Study of Lurbinectedin in Combination With Doxorubicin Versus Doxorubicin Alone as First-line Treatment in Patients With Metastatic Leiomyosarcoma
NCT Heidelberg » Für Ärzte » Studien » Sarkome » Weichteilsarkome
Datum: 2025-10-24
17.
Prospective Comparative Effectiveness Trial of Carbon Ion Therapy, Surgery, and Proton Therapy for the Management of Pelvic Sarcomas (Soft Tissue/Bone) Involving the Bone
NCT Heidelberg » Für Ärzte » Studien » Sarkome » Weichteilsarkome
Datum: 2025-10-24
18.
Prospective Comparative Effectiveness Trial of Carbon Ion Therapy, Surgery, and Proton Therapy for the Management of Pelvic Sarcomas (Soft Tissue/Bone) Involving the Bone
NCT Heidelberg » Für Ärzte » Studien » Sarkome » Knochensarkome
Datum: 2025-10-24
19.
A Phase 1b/2, Multicenter Study of Vorasidenib in Combination With Temozolomide (TMZ) in Participants With IDH1- or IDH2-mutant Glioma
NCT Heidelberg » Für Ärzte » Studien » Neuroonkologische Tumoren » Gliome (Grad I-III)
Datum: 2025-10-24
20.
A Phase 1b/2, Multicenter Study of Vorasidenib in Combination With Temozolomide (TMZ) in Participants With IDH1- or IDH2-mutant Glioma
NCT Heidelberg » Für Ärzte » Studien » Neuroonkologische Tumoren » Gliome (Grad I-III)
Datum: 2025-10-24